Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer

被引：0
|
作者：
Kazumi Sano
Kazuhiko Nakadate
Kazuhiko Hanada
机构：
[1] Meiji Pharmaceutical University,Department of Pharmacometrics and Pharmacokinetics
[2] Meiji Pharmaceutical University,Department of Basic Biology, Educational and Research Center for Pharmacy
来源：
BMC Cancer | / 20卷
关键词：
Minocycline application; Improvement skin disorder; Afatinib; EGFR; NSCLC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer
    Sano, Kazumi
    Nakadate, Kazuhiko
    Hanada, Kazuhiko
    BMC CANCER, 2020, 20 (01)
  • [2] Feasibility of Rebiopsy in Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
    Hasegawa, Takaaki
    Sawa, Toshiyuki
    Futamura, Yohei
    Horiba, Akane
    Ishiguro, Takashi
    Marui, Tsutomu
    Yoshida, Tsutomu
    INTERNAL MEDICINE, 2015, 54 (16) : 1977 - 1980
  • [3] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib
    Morin-Ben Abdallah, Sami
    Hirsh, Vera
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [4] Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2013, 76 (05) : 249 - 257
  • [5] Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Asami, Kazuhiro
    Atagi, Shinji
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 646 - 659
  • [6] Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations
    De Pas, Tommaso
    Toffalorio, Francesca
    Manzotti, Michela
    Fumagalli, Caterina
    Spitaleri, Gianluca
    Catania, Chiara
    Delmonte, Angelo
    Giovannini, Monica
    Spaggiari, Lorenzo
    de Braud, Filippo
    Barberis, Massimo
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1895 - 1901
  • [7] Effectiveness Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors On Non-Small Cell Lung Cancer Harboring Rare EGFR Mutations
    Chang, L. -C.
    Chen, K. -Y.
    Shih, J. -Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [8] Estrogen receptor β1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer
    Fu, Shengling
    Liu, Changyu
    Huang, Quanfu
    Fan, Sheng
    Tang, Hexiao
    Fu, Xiangning
    Ai, Bo
    Liao, Yongde
    Chu, Qian
    ONCOLOGY REPORTS, 2018, 39 (03) : 1313 - 1321
  • [9] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Kujtan, Lara
    Subramanian, Janakiraman
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 547 - 559
  • [10] Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    周清
    魏雪武
    高欣
    何韵婷
    杨潇蓉
    Science Foundation in China, 2019, 27 (01) : 72 - 80
12345